Anika Therapeutics Inc. (ANIK)
Nasdaq: ANIK · Surgical & Medical Instruments & Apparatus · Bedford, MA · filing with the SEC since 1996
Grade5.5
◀ Past 5.7● Present 5.4▶ Future 5.6
Who owns Anika Therapeutics Inc.
As filed with the SECHolders of 5% or more
2
Caligan Partners LP holds 9.95% of Common Stock, par value $0.01 per share, as its SCHEDULE 13D/A filed Jan 27, 2026 says.
Directors and officers
9
report now, of 27 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Caligan Partners LP
SCHEDULE 13D/A · filed Jan 27, 2026 · Common Stock, par value $0.01 per share · 9.95% in Nov 21, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock · 10.6% in Feb 5, 2025
Vanguard Capital Management
SCHEDULE 13G/A · filed Jul 31, 2026 · Common Stock · reported falling below 5%, from 5.19% in Apr 29, 2026
Dimensional Fund Advisors LP
SCHEDULE 13G/A · filed Jan 23, 2025 · Common Stock · reported falling below 5%
BlackRock Portfolio Management LLC
SCHEDULE 13G/A · filed Jul 17, 2026 · Common Stock · reported falling below 5%, from 5.5% in Oct 17, 2025
Trigran Investments, Inc.
SCHEDULE 13G/A · filed Jan 8, 2026 · Common Stock, Par Value $0.01 Per Share · reported falling below 5%, from 11.2% in Nov 7, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What ANIK reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 3, 2026.
Insider tradesForm 4
0sales
4purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$300,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 27 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Fischetti Gary P | director | 0 | $0 | 0 | 2 | $0 |
| Griffin Stephen D. | President and CEO | 0 | $0 | 0 | 1 | $100,000 |
| Henneman John B III | director | 0 | $0 | 0 | 1 | $100,000 |